Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer

NCT03727126 · GEM Hospital & Research Center · Updated 14 Oct 2020

What is being tested
Robotic esophagectomy; Thoracolaparoscopic esophagectomy
For
Esophageal Cancer
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 40 people. The full rules are on the registry page.
Where
India (2 sites)
When
Starts or started 1 Nov 2018, ends 1 Jan 2021. Registered 1 Nov 2018.
Results
None posted yet.

In the researchers' words

Esophageal cancer is a debilitating condition. The treatment involved is complex requiring a combination of chemotherapy and surgery in most cases. Complete removal of the tumor and the adjacent lymph nodes is of utmost importance in improving the survival. Lymph node yield following surgery helps in proper staging of the disease and is an important prognosticating variable. It is hypothesized that the lymph node yield following robotic esophagectomy is higher than that following thoracolaparoscopic esophagectomy. The study aims to compare the short term oncological outcomes following robotic esophagectomy and thoracolaparoscopic esophagectomy for carcinoma esophagus.
ClinicalTrials.gov, NCT03727126

Sites

  • GEM Hospital & Research CenterChennai, Tamil Nadu, India
  • GEM Hospital & Research CenterCoimbatore, Tamil Nadu, India